메뉴 건너뛰기
American Journal of Psychiatry
Volumn 172, Issue 9, 2015, Pages 820-821
Brexpiprazole: A new antipsychotic following in the footsteps of aripiprazole
Author keywords

[No Author keywords available]
Indexed keywords

ARIPIPRAZOLE; BIFEPRUNOX; BREXPIPRAZOLE; DOPAMINE; DOPAMINE 2 RECEPTOR; PLACEBO; SEROTONIN 1A RECEPTOR; NEUROLEPTIC AGENT; QUINOLONE DERIVATIVE; THIOPHENE DERIVATIVE;
EID: 84941126254     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.15060741     Document Type: Editorial
Times cited : (9)
References (7)
  • 1
    • 84937234454 scopus 로고    scopus 로고
    • Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia: A 6-week randomized, double-blind, placebo-controlled trial
    • Correll CU, Skuban A, Ouyang J, et al: Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2015;172:870-880
    • (2015) Am J Psychiatry , vol.172 , pp. 870-880
    • Correll, C.U.1    Skuban, A.2    Ouyang, J.3
  • 2
    • 84936163980 scopus 로고    scopus 로고
    • Forecasting Medicaid expenditures for antipsychotic medications
    • Slade EP, Simoni-Wastila L: Forecasting Medicaid expenditures for antipsychotic medications. Psychiatr Serv 2015; 66:713-718
    • (2015) Psychiatr Serv , vol.66 , pp. 713-718
    • Slade, E.P.1    Simoni-Wastila, L.2
  • 3
    • 51849168937 scopus 로고    scopus 로고
    • Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: Results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study
    • Casey DE, Sands EE, Heisterberg J, et al: Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study. Psychopharmacology (Berl) 2008; 200:317-331
    • (2008) Psychopharmacology (Berl) , vol.200 , pp. 317-331
    • Casey, D.E.1    Sands, E.E.2    Heisterberg, J.3
  • 4
    • 84884161208 scopus 로고    scopus 로고
    • Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis
    • Leucht S, Cipriani A, Spineli L, et al: Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013; 382:951-962
    • (2013) Lancet , vol.382 , pp. 951-962
    • Leucht, S.1    Cipriani, A.2    Spineli, L.3
  • 5
    • 84903982078 scopus 로고    scopus 로고
    • Brexpiprazole I: In vitro and in vivo characterization of a novel serotonin-dopamine activity modulator
    • Maeda K, Sugino H, Akazawa H, et al: Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator. J Pharmacol Exp Ther 2014; 350:589-604
    • (2014) J Pharmacol Exp Ther , vol.350 , pp. 589-604
    • Maeda, K.1    Sugino, H.2    Akazawa, H.3
  • 6
    • 84928640856 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
    • Kane JM, Skuban A, Ouyang J,et al: A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia. Schizophr Res 2015; 164:127-135
    • (2015) Schizophr Res , vol.164 , pp. 127-135
    • Kane, J.M.1    Skuban, A.2    Ouyang, J.3
  • 7
    • 33749333592 scopus 로고    scopus 로고
    • Comparative effectiveness of antipsychotic drugs: A commentary on Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
    • Lieberman JA: Comparative effectiveness of antipsychotic drugs: a commentary on Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). Arch Gen Psychiatry 2006; 63:1069-1072
    • (2006) Arch Gen Psychiatry , vol.63 , pp. 1069-1072
    • Lieberman, J.A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.